These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30877304)

  • 1. Circulating (1→3)-β-D-glucan Is Associated With Immune Activation During Human Immunodeficiency Virus Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Ponte R; Chen J; Kema I; Jenabian MA; Costinuik CT; Lebouché B; Thomas R; Coté P; Leblanc R; Baril JG; Durand M; Chartrand-Lefebvre C; Tremblay C; Ancuta P; Bernard NF; Sheppard DC; Routy JP;
    Clin Infect Dis; 2020 Jan; 70(2):232-241. PubMed ID: 30877304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating (1 → 3)-β-D-Glucan as an immune activation marker decreased after ART in people living with HIV.
    Xun J; Guo S; Xu Y; Chen R; Tang Q; Zhang X; Liu D; Zhang R; Shen Y; Liu L; Wan J; Chen J; Lu H
    Front Public Health; 2022; 10():981339. PubMed ID: 36187617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.
    Ramendra R; Isnard S; Mehraj V; Chen J; Zhang Y; Finkelman M; Routy JP
    Front Immunol; 2019; 10():465. PubMed ID: 30967860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
    Front Immunol; 2019; 10():289. PubMed ID: 30846990
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus.
    Isnard S; Ramendra R; Dupuy FP; Lin J; Fombuena B; Kokinov N; Kema I; Jenabian MA; Lebouché B; Costiniuk CT; Ancuta P; Bernard NF; Silverman MS; Lakatos PL; Durand M; Tremblay C; Routy JP;
    J Infect Dis; 2020 Jan; 221(1):110-121. PubMed ID: 31504638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.
    Iannetta M; Savinelli S; Rossi R; Mascia C; Marocco R; Vita S; Zuccalà P; Zingaropoli MA; Mengoni F; Massetti AP; Falciano M; d'Ettorre G; Ciardi MR; Mastroianni CM; Vullo V; Lichtner M
    Immunobiology; 2019 Mar; 224(2):231-241. PubMed ID: 30522891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Low Frequency of IL-17-Producing CD8
    Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
    Front Immunol; 2018; 9():2502. PubMed ID: 30420859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
    Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
    AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
    Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
    Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
    Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
    Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
    Front Immunol; 2019; 10():2849. PubMed ID: 31867010
    [No Abstract]   [Full Text] [Related]  

  • 12. Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.
    Muenchhoff M; Healy M; Singh R; Roider J; Groll A; Kindra C; Sibaya T; Moonsamy A; McGregor C; Phan MQ; Palma A; Kloverpris H; Leslie A; Bobat R; LaRussa P; Ndung'u T; Goulder P; Sobieszczyk ME; Archary M
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):46-55. PubMed ID: 28670966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
    Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
    Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
    Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
    J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection.
    Zanni MV; Toribio M; Robbins GK; Burdo TH; Lu MT; Ishai AE; Feldpausch MN; Martin A; Melbourne K; Triant VA; Suchindran S; Lee H; Hoffmann U; Williams KC; Tawakol A; Grinspoon SK
    JAMA Cardiol; 2016 Jul; 1(4):474-80. PubMed ID: 27438325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls.
    Ramendra R; Isnard S; Lin J; Fombuena B; Ouyang J; Mehraj V; Zhang Y; Finkelman M; Costiniuk C; Lebouché B; Chartrand-Lefebvre C; Durand M; Tremblay C; Ancuta P; Boivin G; Routy JP
    Clin Infect Dis; 2020 Sep; 71(6):1438-1446. PubMed ID: 31608409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating β-d-Glucan as a Marker of Subclinical Coronary Plaque in Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus.
    Isnard S; Fombuena B; Sadouni M; Lin J; Richard C; Routy B; Ouyang J; Ramendra R; Peng X; Zhang Y; Finkelman M; Tremblay-Sher D; Tremblay C; Chartrand-Lefebvre C; Durand M; Routy JP
    Open Forum Infect Dis; 2021 Jun; 8(6):ofab109. PubMed ID: 34189152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Intestinal Permeability and Fungal Translocation in Ugandan Children With Human Immunodeficiency Virus.
    Dirajlal-Fargo S; El-Kamari V; Weiner L; Shan L; Sattar A; Kulkarni M; Funderburg N; Nazzinda R; Karungi C; Kityo C; Musiime V; McComsey GA
    Clin Infect Dis; 2020 May; 70(11):2413-2422. PubMed ID: 31260509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.
    Mehraj V; Jenabian MA; Ponte R; Lebouché B; Costiniuk C; Thomas R; Baril JG; LeBlanc R; Cox J; Tremblay C; Routy JP;
    AIDS; 2016 Jun; 30(10):1617-27. PubMed ID: 27045377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.